Literature DB >> 23817226

Enhancement of autophagy by simvastatin through inhibition of Rac1-mTOR signaling pathway in coronary arterial myocytes.

Yu-Miao Wei1, Xiang Li, Ming Xu, Justine M Abais, Yang Chen, Christopher R Riebling, Krishna M Boini, Pin-Lan Li, Yang Zhang.   

Abstract

BACKGROUND/AIMS: In addition to their action of lowering blood cholesterol levels, statins modulate biological characteristics and functions of arterial myocytes such as viability, proliferation, apoptosis, survival and contraction. The present study tested whether simvastatin, as a prototype statin, enhances autophagy in coronary arterial myocytes (CAMs) to thereby exert their beneficial effects in atherosclerosis. METHODS AND
RESULTS: Using flow cytometry, we demonstrated that simvastatin significantly increased the autophagsome formation in CAMs. Western blot analysis confirmed that simvastatin significantly increased protein expression of typical autophagy markers LC3B and Beclin1 in these CAMs. Confocal microscopy further demonstrated that simvastatin increased fusion of autophagosomes with lysosomes, which was blocked by autophagy inhibitor 3-methyladenine or silencing of Atg7 genes. Simvastatin reduced mammalian target of rapamycin (mTOR) activity, which was reversed by Rac1-GTPase overexpression and the mTOR agonist phosphatidic acid. Moreover, both Rac1-GTPase overexpression and activation of mTOR by phosphatidic acid drastically blocked simvastatin-induced autophagosome formation in CAMs. Interestingly, simvastatin increased protein expression of a contractile phenotype marker calponin in CAMs, which was blocked by autophagy inhibitor 3-methyladenine. Simvastatin markedly reduced proliferation of CAMs under both control and proatherogenic stimulation. However, this inhibitory effect of simvastatin on CAM proliferation was blocked by by autophagy inhibitor 3-methyladenine or silencing of Atg7 genes. Lastly, animal experiments demonstrated that simvastatin increased protein expression of LC3B and calponin in mouse coronary arteries.
CONCLUSION: Our results indicate that simvastatin inhibits the Rac1-mTOR pathway and thereby increases autophagy in CAMs which may stabilize CAMs in the contractile phenotype to prevent proliferation and growth of these cells.
Copyright © 2013 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23817226      PMCID: PMC3753088          DOI: 10.1159/000350111

Source DB:  PubMed          Journal:  Cell Physiol Biochem        ISSN: 1015-8987


  45 in total

1.  Suppression of Gαs synthesis by simvastatin treatment of vascular endothelial cells.

Authors:  Ruqin Kou; Takashi Shiroto; Juliano L Sartoretto; Thomas Michel
Journal:  J Biol Chem       Date:  2011-12-05       Impact factor: 5.157

2.  Membrane raft-lysosome redox signalling platforms in coronary endothelial dysfunction induced by adipokine visfatin.

Authors:  Min Xia; Chun Zhang; Krishna M Boini; Audrey M Thacker; Pin-Lan Li
Journal:  Cardiovasc Res       Date:  2010-09-07       Impact factor: 10.787

Review 3.  Inflammatory markers, cholesterol and statins: pathophysiological role and clinical importance.

Authors:  Luigi Marzio Biasucci; Gina Biasillo; Antonella Stefanelli
Journal:  Clin Chem Lab Med       Date:  2010-09-27       Impact factor: 3.694

Review 4.  Mechanisms for the anti-inflammatory effects of statins.

Authors:  De-xiu Bu; Gabriel Griffin; Andrew H Lichtman
Journal:  Curr Opin Lipidol       Date:  2011-06       Impact factor: 4.776

5.  NAD(P)H oxidase-dependent intracellular and extracellular O2•- production in coronary arterial myocytes from CD38 knockout mice.

Authors:  Ming Xu; Yang Zhang; Min Xia; Xiao-Xue Li; Joseph K Ritter; Fan Zhang; Pin-Lan Li
Journal:  Free Radic Biol Med       Date:  2011-11-03       Impact factor: 7.376

Review 6.  mTORC1 signaling: what we still don't know.

Authors:  Xuemin Wang; Christopher G Proud
Journal:  J Mol Cell Biol       Date:  2010-12-07       Impact factor: 6.216

7.  Adiponectin induces vascular smooth muscle cell differentiation via repression of mammalian target of rapamycin complex 1 and FoxO4.

Authors:  Min Ding; Yi Xie; Robert J Wagner; Yu Jin; Ana Catarina Carrao; Lucinda S Liu; Anthony K Guzman; Richard J Powell; John Hwa; Eva M Rzucidlo; Kathleen A Martin
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-03-31       Impact factor: 8.311

8.  Inhibition of AMPK-dependent autophagy enhances in vitro antiglioma effect of simvastatin.

Authors:  Maja Misirkic; Kristina Janjetovic; Ljubica Vucicevic; Gordana Tovilovic; Biljana Ristic; Urosh Vilimanovich; Ljubica Harhaji-Trajkovic; Mirjana Sumarac-Dumanovic; Dragan Micic; Vladimir Bumbasirevic; Vladimir Trajkovic
Journal:  Pharmacol Res       Date:  2011-08-18       Impact factor: 7.658

9.  mTORC1 and mTORC2 regulate EMT, motility, and metastasis of colorectal cancer via RhoA and Rac1 signaling pathways.

Authors:  Pat Gulhati; Kanika A Bowen; Jianyu Liu; Payton D Stevens; Piotr G Rychahou; Min Chen; Eun Y Lee; Heidi L Weiss; Kathleen L O'Connor; Tianyan Gao; B Mark Evers
Journal:  Cancer Res       Date:  2011-03-23       Impact factor: 12.701

10.  Rac1 regulates the activity of mTORC1 and mTORC2 and controls cellular size.

Authors:  Abdelhafid Saci; Lewis C Cantley; Christopher L Carpenter
Journal:  Mol Cell       Date:  2011-04-08       Impact factor: 17.970

View more
  63 in total

Review 1.  Advances in understanding mechanisms and therapeutic targets to treat comorbid depression and cardiovascular disease.

Authors:  Brittany S Pope; Susan K Wood
Journal:  Neurosci Biobehav Rev       Date:  2020-06-26       Impact factor: 8.989

2.  A Peculiar Formula of Essential Amino Acids Prevents Rosuvastatin Myopathy in Mice.

Authors:  Giuseppe D'Antona; Laura Tedesco; Chiara Ruocco; Giovanni Corsetti; Maurizio Ragni; Andrea Fossati; Elisa Saba; Francesca Fenaroli; Mery Montinaro; Michele O Carruba; Alessandra Valerio; Enzo Nisoli
Journal:  Antioxid Redox Signal       Date:  2016-07-14       Impact factor: 8.401

3.  Contribution of transcription factor EB to adipoRon-induced inhibition of arterial smooth muscle cell proliferation and migration.

Authors:  Yun-Ting Wang; Jiajie Chen; Xiang Li; Michihisa Umetani; Yang Chen; Pin-Lan Li; Yang Zhang
Journal:  Am J Physiol Cell Physiol       Date:  2019-09-04       Impact factor: 4.249

4.  Effects of insulin on the proliferation and global gene expression profile of A7r5 cells.

Authors:  Huiming Duan; Xiaotao Feng; Xiaoqi Huang
Journal:  Mol Biol Rep       Date:  2021-02-08       Impact factor: 2.316

Review 5.  Autophagy: an emerging therapeutic target in vascular diseases.

Authors:  Cécile Vindis
Journal:  Br J Pharmacol       Date:  2015-02-27       Impact factor: 8.739

6.  Chronic HMGCR/HMG-CoA reductase inhibitor treatment contributes to dysglycemia by upregulating hepatic gluconeogenesis through autophagy induction.

Authors:  Hye Jin Wang; Jae Yeo Park; Obin Kwon; Eun Yeong Choe; Chul Hoon Kim; Kyu Yeon Hur; Myung-Shik Lee; Mijin Yun; Bong Soo Cha; Young-Bum Kim; Hyangkyu Lee; Eun Seok Kang
Journal:  Autophagy       Date:  2015-11-02       Impact factor: 16.016

7.  Regulation of autophagic flux by dynein-mediated autophagosomes trafficking in mouse coronary arterial myocytes.

Authors:  Ming Xu; Xiao-Xue Li; Jing Xiong; Min Xia; Erich Gulbins; Yang Zhang; Pin-Lan Li
Journal:  Biochim Biophys Acta       Date:  2013-10-01

8.  Control of autophagy maturation by acid sphingomyelinase in mouse coronary arterial smooth muscle cells: protective role in atherosclerosis.

Authors:  Xiang Li; Ming Xu; Ashley L Pitzer; Min Xia; Krishna M Boini; Pin-Lan Li; Yang Zhang
Journal:  J Mol Med (Berl)       Date:  2014-01-25       Impact factor: 4.599

9.  Augmentation of autophagy by atorvastatin via Akt/mTOR pathway in spontaneously hypertensive rats.

Authors:  Wei Wang; Hao Wang; Qing-Xin Geng; Hua-Ting Wang; Wei Miao; Bo Cheng; Di Zhao; Guang-Min Song; Groban Leanne; Zhuo Zhao
Journal:  Hypertens Res       Date:  2015-07-30       Impact factor: 3.872

Review 10.  Immune Cell Regulatory Pathways Unexplored as Host-Directed Therapeutic Targets for Mycobacterium tuberculosis: An Opportunity to Apply Precision Medicine Innovations to Infectious Diseases.

Authors:  Robert N Mahon; Richard Hafner
Journal:  Clin Infect Dis       Date:  2015-10-15       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.